Neurobehavioral Manifestations  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT01261741 / 2010-020737-50: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Completed
2
299
Europe
Memantine, Placebo
Merz Pharmaceuticals GmbH
Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment, Memory, Concentration or Attention Problems
08/11
09/11
NCT00200538: Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Completed
2
52
Europe
memantine
Nantes University Hospital
Dementia
 
 

Download Options